Clinical Trial Update: Green Tea Intake for the Maintenance of Complete Remission in Women With Advanced Ovarian Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating green tea intake for maintaining complete remission in women with advanced ovarian carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Carcinoma

Snippet

Sponsor: CHU de Quebec-Universite Laval | Conditions: Ovarian Carcinoma | Phase 2 | Status: COMPLETED